A strain-release-driven, cation-templated nucleophilic 7-and 8-exotrig-cyclization of tethered Boc-protected amines to cyclopropenes is described. The featured reaction proceeds in diastereoand regioselective fashion and allows for preparation of the corresponding 2,5diazabicyclo[5.1.0]octan-6-ones and 2,6-diazabicyclo[6.1.0]nonan-7-ones as sole products in high yields. Preliminary studies on anticancer activities of these novel cyclopropane-fused medium heterocycles were performed.
INTRODUCTION
The cyclopropene double bond is characterized by enhanced strain energy and much greater electrophilicity as compared to normal olefins. This feature allows for the utilization of strain-release driven addition of various nucleophilic entities across the C=C bond of cyclopropenes in design of bio-orthogonal transformations 1 or for the development of synthetic strategies toward novel cyclopropyl scaffolds. 2 Employment of carbon-, 3 nitrogen-, 4 oxygen-, 5 sulfur-, 6 or halogen-based 7 nucleophiles has been demonstrated in the intermolecular mode of the ring-retentive addition (Scheme 1, eq 1). The intramolecular version of this reaction involving nucleophilic species tethered to cyclopropenes and leading to the formation of fused bicyclic ring systems is much more challenging. Synthetic methodology employing 5-exo-trig nucleophilic attack by stabilized carbanions 3 allowing access to bicyclic lactams 4 (Scheme 1, eq 2) was recently developed in our group. 8 We also demonstrated several modes of potassium-templated cyclizations involving nucleophilic alkoxides 5 that afford medium sized cyclic ethers 6 (Scheme 1, eq 3). 9 During these studies, novel scaffolds were identified possessing promising biological activity, 9a which justified further synthetic efforts, especially toward medium sized cyclic amines 8, that could mimic βor γ-turns of polypeptides. Herein, we wish to disclose our initial progress toward this goal.
RESULTS AND DISCUSSION
At first glance, the planned cyclization involving amine-based nucleophilic entities seemed to be a reasonably straightforward extension of the work previously performed with alkoxides but, as usual, the devil was in the details. It should be pointed out that for successful base-assisted addition of the heteroatom-based entities across C=C bond of cyclopropenes, fine balance between nucleophilicity and acidity must be maintained. 4, 5 Thus, the ring-retentive reaction of cyclopropenes with primary amines (9, X = NH 2 , NHAlk) cannot be achieved because the nucleophilicity of these neutral amines is much lower that of alkoxides, and their acidity is not sufficient to produce much more reactive anionic entities in the presence of typically employed weak bases. Increasing the strength of the base proved counterproductive because concurrent deprotonation of acidic C−H bonds of cyclopropene occurs, greatly diminishing its electrophilicity. At higher temperature, it was possible to force a thermally induced intramolecular nucleophilic attack in substrate 9, but the resulting donor−acceptor cyclopropane 10 tended toward facile ring-cleavage 10, 11 and subsequent decomposition of cyclic imine 11 (Scheme 2). 12 Arguably, the best solution to this problem would be the employment of an appropriate protecting group at the amine function, acidifying the N−H bond in the precursor and moderating the electron-donating character of the nitrogen atom in the cyclic product. Given the availability of the corresponding starting materials for this preliminary communication, we decided to concentrate on reactivity of Boc-protected amines 7. To this end, 1phenylcycloprop-2-ene-1-carboxylic acid 12a was subjected to the acylation reaction with tert-butyl (2-aminoethyl)carbamate 13a. Without purification, the resulting amide 7aa was treated with powdered KOH to afford the desired 2,5-diazabicyclo [5.1.0] octan-6-one 8aa as the sole product in 86% overall yield (Scheme 3, entry1) . This reaction proved to be pretty general for 7-exo-trig cyclization showing high tolerance for substituents at the amide nitrogen and at the C-1 of cyclopropene. It was shown that the starting amines could be protected not only by benzyl or substituted benzyl groups but also by alkyl (entries 4, 5, 9, 13−15, and 17) or 2-picolyl moieties (entry 6). The aryl group at quaternary center of cyclopropene (C-1) can bear alkoxy (12b) or halogen substituents (12c −f) . All sevenmembered bicyclic amides were obtained in very high yields as sole products (Scheme 3).
Similarly, acylation of cyclopropene-3-carboxylic acids 12a, e, and f with N-benzylated derivatives of (3-aminopropyl)-carbamate 13h−j afforded the corresponding tethered carbamates 7 in crude form (Scheme 4). After treatment with a base, the latter underwent smooth 8-exo-trig cyclization, leading to the formation of 2,6-diazabicyclo[6.1.0]nonan-7ones 8ah, 8eh, 8ej, and 8fh (Scheme 4, entries 18−21) . Next, we investigated if the diastereoselectivity of this reaction could be affected by the presence of additional stereogenic centers. First, we employed chiral cycloprop-2-enecarboxylic acids 12g and h (in racemic form, Scheme 5). They were converted into monocarbamates 13h and j uneventfully, and the following base-assisted cyclizations afforded tertiary amide species 7, possessing chiral cyclopropene units (Scheme 5). We were pleased to find that the reaction of these precursors proceeded regio-and diastereoselectively, affording in high yields seven-(8ga, 8ha, and 8hb) and eight-membered (8gh and 8hi) heterocycles as sole products with relative configurations (1S*,7S*,8R*) and (1S*,8S*,9R*), respectively (Scheme 5, entries 22−26) . Overall, the addition of N−H moiety across C==C bond of cyclopropene proceeded in a formal syn-fashion. Next, reaction of tethered carbamate 7ck assembled by acylation of to the one recently reported for assembly of cyclopropane-fused oxazepanones (6, n = 1) via 7-exo-trig cyclizations of tethered chiral alkoxides. 9a As mentioned above, the obtained structures constitute very attractive biological probes as this unique heterocyclic scaffold just recently emerged on the chemical space map. 13 Accordingly, we performed a preliminary biological evaluation of a few representative compounds for anticancer activity using HeLa cell line (ATCC CCL-2) as a model for human cervical adenocarcinoma (Table 1) through the measurements of mitochondrial dehydrogenase activities using the MTT method. 14 Our preliminary tests revealed that some of obtained compounds possess strong anticancer activity, and the level of biological activity is very dependent on the character of R 1 and R 2 substituents in designed structures (Scheme 2). For example, the changing of R 2 from aryl or benzyl groups to alkyl group eliminates the antiproliferative activity of synthesized compounds 8 completely. The same effect was observed as a result of the replacement of H with Ph at the CH 2 -group of the cyclopropane ring. At the same time, significant improvement of biological activity (almost threefold) was achieved after incorporation of Br in the meta-position of the aryl ring at C-1 (R 1 substituent). Thus, the obtained compounds 8ec and 8ej revealed great promise as novel anticancer scaffolds and will be the subject of further investigations.
CONCLUSION
In conclusion, a novel and highly efficient cyclization involving alkali-metal templated ringretentive exo-trig nucleophilic attack of tethered amine moiety (activated by carbamate group) at the cyclopropene double bond was demonstrated. It was shown that this reaction proceeds in a highly regio-and diastereoselective fashion, which allows access to previously unknown cyclopropane-fused medium-sized nitrogen-based heterocycles as sole products. Utilization of chiral diamines derived from natural amino acids allows for expeditious access to enantiomerically pure molecules. Preliminary evaluation of the bioactivity of these previously unknown drug-like scaffolds was performed to reveal several structures with promising anticancer properties. Further synthetic studies utilizing a variety of different activating groups and building a library for further SAR-investigations are currently underway in our laboratories. consecutively through two columns filled with activated alumina and stored over molecular sieves under nitrogen. Water was purified by dual stage deionization followed by dual stage reverse osmosis. Anhydrous THF was obtained by refluxing commercially available solvent over calcium hydride followed by distillation in a stream of dry nitrogen. All other reagents and solvents were purchased from commercial vendors and used as received.
Biological Studies.
Cell culture: HeLa cells were cultured in DMEM supplemented with 10% FBS. To evaluate antiproliferative properties of the synthesized compounds, the cells were trypsinized and seeded 4 × 10 3 cells per well into 96-well microtiter plates. The cells were grown for 24 h before treatment.
MTT assay for HeLa: All compounds were dissolved in DMSO at a concentration of either 100 or 50 mM prior to cell treatment. The cells were treated at concentrations ranging from 0.004 to 100 μM and incubated for 48 h in 200 μL of media. Twenty microliters of MTT reagent in serum-free medium (5 mg/mL) was added to each well and incubated further for 2 h. Media was removed, and the resulting formazan crystals were resolubilized in 100 μL of DMSO. A490 was measured using a Thermomax Molecular Device plate reader. The experiments were performed in quadruplicate and repeated at least twice for each compound per cell line. Cells treated with 0.1% DMSO were used as a negative control, and phenyl arsine oxide (PAO) was used as a positive killing control.
Preparation of Starting Materials.
1-(4-Methoxyphenyl)-cycloprop-2-ene-1-carboxylic Acid (12b).-Typical procedure: Methyl (4-methoxyphenyl)acetate (6.86 g, 41.3 mmol, 1.00 equiv), and tosyl azide (9.0 g, 45.4 mmol, 1.1 equiv) were stirred in acetonitrile (150 mL) at 0 °C, and DBU (7.54 g, 49.5 mmol, 1.2 equiv) was added dropwise. Upon complete addition, the reaction was warmed to room temperature and stirred overnight. The solvent was then removed in vacuum, and the residue was partitioned between saturated ammonium chloride (100 mL) and methylene chloride (75 mL). The aqueous phase was then extracted with methylene chloride (3 × 30 mL) . Combined organic phases were then washed with brine, dried with MgSO 4 , filtered, and concentrated. The recovered material was then filtered through a short pad of silica gel (15 g) as solution in hexanes. The filtrate was concentrated in vacuum to obtain crude methyl 2-diazo-2-(4-methoxyphenyl)acetate as a red oil. This material was then mixed with trimethylsilylacetylene (2 mL) and added via a syringe pump over 18 h to a stirring and refluxing suspension of rhodium(II) acetate dimer (27.4 mg, 0.124 mmol, 0.3 mol %) in trimethylsilylacetylene (47 mL, 413 mmol, 10.0 equiv). The reaction was monitored by gas chromatography until complete consumption of the starting material was observed. Then, the reflux condenser was replaced with a distilling head, and most of the trimethylsilylacetylene was recovered by distillation at ambient pressure. The residual solvent was then removed under vacuum. The reaction mixture was then purified by short column chromatography, eluting with a mixture of hexane:EtOAc (10:1). Crude ethyl 1-(4methoxyphenyl)-2-(trimethylsilyl)cycloprop-2-ene-1-carboxylate was obtained as a yellowish oil, which was stirred at 0 °C in a mixture of methanol and THF (1:1, 200 mL). An aqueous solution of sodium hydroxide (2 M, 200 mL) was added dropwise, and the mixture was stirred for 18h. Organic solvents were then removed under vacuum, and the remaining aqueous solution was washed with dichloromethane (3 × 50 mL). The mixture was acidified to pH 2 with 2 M aqueous HCl and extracted with dichloromethane (3 × 50 mL). The combined organic phases were washed with brine, dried with MgSO 4 , filtered, and concentrated. The obtained product was purified by column chromatography on silica gel eluting with a mixture of hexane:EtOAc (2:1). The title compound was obtained as an offwhite crystalline solid (R f 0.3, mp 115−116 °C). Overall yield 2.198 g (11.6 mmol, 28%) . 1 H NMR (500 MHz, CDCl 3 ) δ 7.22 (s, 2H), 7. 24−7.19 (m, 2H), 6.87−6.81 (m, 2H) , 3.79 (s, 3H) . 13 C NMR (126 MHz, CDCl 3 ) δ 180. 7, 158.5, 132.9, 129.5 (+, 2C) 
1-(3-Chlorophenyl)cycloprop-2-ene-1-carboxylic Acid (12d).-This compound was
obtained from methyl (3-chlorophenyl)acetate(5.65 g, 33.1 mmol) using the protocol described for the synthesis of 1-(4-methoxyphenyl)cycloprop-2-ene-1-carboxylic acid (vide supra). The title compound was obtained as an off-white crystalline solid (mp 84−86 °C). Yield 4.71 g (24.2 mmol, 73%). 1 H NMR (500 MHz, CDCl 3 ) δ 7.28 (td, J = 1.8, 0.6 Hz, 1H), 7. 24−7.22 (m, 1H) , 7.21 (t, J = 1.9 Hz, 1H), 7.20 (s, 2H), 7. 19−7.17 (m, 1H) . 13 (2 drops), and freshly distilled anhydrous dichloromethane (7 mL) under nitrogen atmosphere. Oxalyl chloride (400 μL, 592 mg, 4.68 mmol, 1.5 equiv) was then added dropwise, and the mixture was stirred at room temperature for 2 h. The solution was concentrated in a stream of nitrogen; then, the residue was subjected to a high vacuum, dissolved in anhydrous dichloromethane (2.0 mL), and added dropwise to a stirred solution of tert-butyl (2-(benzylamino)ethyl)carbamate (13a) 17 (375 mg, 1.5 mmol, 1.2 equiv) and triethylamine (1.3 mL, 948 mg, 9.36 mmol, 3.0 equiv) in anhydrous dichloromethane (3.0 mL). The reaction mixture was stirred at room temperature for 18 h and then partitioned between water (15 mL) and dichloromethane (20 mL). The aqueous phase was diluted with 5 mL of concentrated aqueous solution of ammonium chloride. The organic phase was then washed with saturated aq NH 4 Cl (3 × 10 mL). The combined aqueous layers were backextracted once with 10 mL of dichloro-methane, which was combined with other organic phases, washed with brine, dried with MgSO 4 , filtered, and concentrated. The crude product tert-butyl (2-(N-benzyl-1-phenylcycloprop-2-ene-1-carboxamido)ethyl)carbamate (7aa) was filtered through a silica plug using EtOAc and then was concentrated and used at the cyclization step as-is without additional purification. An oven-dried 3 mL Wheaton vial was charged with powdered KOH (21.4 mg, 0.381 mmol) and anhydrous THF (800 μL). Crude carbamate 7aa (60 mg, 0.153 mmol) was added as a solution in anhydrous THF (400 μL).
Synthesis of Medium
The mixture was vigorously stirred at 35 °C for 8 h; then, the reaction mixture was filtered through short plug of silica gel eluting with EtOAc, and the eluate was concentrated in vacuum. The titled product was isolated by column chromatography eluting with a hexanes:EtOAc mixture ( according to the typical procedure starting from 1- (3-bromophenyl) 28.5 (+, 3C), 26.1 (−), 13.5 (+) . FTIR (NaCl, cm −1 ): 2975, 2932, 1699, 1651, 1512, 1476, 1395, 1366, 1345, 1250, 1234, 1148, 1064, 834, 778. 19 , 2928, 2871, 1702, 1652, 1593, 1562, 1477, 1428, 1367, 1345, 1297, 1248, 1247, 1175, 1062, 856, 777, 693, 664 (−) . FTIR (NaCl, cm −1 ): 2973, 2925, 1692, 1639, 1593, 1562, 1509, 1477, 1414, 1383, 1367, 1256, 1221, 1154, 1107, 969, 858, 819, 769, 689. 19 (−) . FTIR (NaCl, cm −1 ): 2961, 2924, 2854, 1700, 1654, 1591, 1474, 1435, 1394, 1366, 1345, 1251, 1146, 1066, 756, 698, 610 . 24.8 (−) . FTIR (NaCl, cm −1 ): 2925 , 2854 , 1692 , 1640 , 1631 , 1585 , 1470 , 1453 , 1416 , 1383 , 1366 , 1288 , 1253 , 1156 , 1105 , 1051 Hz, 1H), 4.11 (t, J = 13.6 Hz, 1H), 2H), 2H), 1H) , 2.30 (t, J = 6.5 Hz, 1H), 1.47 (s, 9H), 1. 1H), 1.12 (dd, J = 8.9, 6.5 Hz, 1H), 1H) . 13 C NMR (126MHz, C 6 D 6 ) δ 169. 7, 155.3, 138.4, 137.4, 135.2, 134 (−) . FTIR (NaCl, cm −1 ): 2972, 2925, 2854, 1690, 1639, 1477, 1454, 1423, 1383, 1366, 1292, 1255, 1159, 1106, 1078, 1059, 968, 860, 750, 733, 699, 602 2, 155.2, 143.4, 138.4, 130.5 (−) . FTIR (NaCl, cm −1 ): 2972, 2925, 1691, 1639, 1593, 1561, 1476, 1454, 1418, 1383, 1366, 1282, 1256, 1158, 1106, 1078, 968, 860, 768, 752, 1366 , 1277 , 1253 , 1174 , 1145 , 1107 , 1079 (−) . FTIR (NaCl, cm −1 ): 2973, 2927, 1701, 1653, 1585, 1473, 1419, 1392, 1366, 1346, 1253, 1168, 1145, 1107, 1078, 1046, 992, 858, 820, 784, 734, (−) . FTIR (NaCl, cm −1 ): 2974, 2928, 1700, 1651, 1515, 1496, 1428, 1393, 1366, 1346, 1250, 1179, 1146, 1065, 1030, 829, 777, 731, 701 . HRMS (ESI-TOF) m/z: [M tert-Butyl(1S*,7S*)-5-Benzyl-7-(3-chlorophenyl)-6-oxo-2,5diazabicyclo[5.1.0]octane-2-carboxylate (8da).-This compound was synthesized according to the typical procedure starting from 1-(3-chlorophenyl)cycloprop-2-ene-1carboxylic acid (12d) (200 mg, 1.03 mmol, 1.0 equiv) and tert-butyl (2-(benzylamino)ethyl)carbamate (13a) 16 (309 mg, 1.23 mmol, 1.2 equiv). After extraction and filtration through a silica plug, crude tert-butyl (2-(N-benzyl-1-(3-chlorophenyl) cycloprop-2-ene-1carboxamido)ethyl)carbamate (7da) was used at the cyclization step as-is without additional purification. To this end, amide 7da (60 mg, 0.141 mmol) was treated with powdered KOH (19.7 mg, 0.351 mmol) . The reaction mixture was vigorously stirred at 35 °C for 8 h. The product was isolated by column chromatography eluting with a hexanes:EtOAc mixture (1:1) as a colorless solid (R f 0.4, mp 100−102 °C). Yield: 52.9 mg (0.124 mmol, 88% (−) . FTIR (NaCl, cm −1 ): 2974, 2926, 2855, 1699, 1651, 1593, 1510, 1478, 1392, 1366, 1344, 1248, 1223, 1148, 1065, 993, 852, 815, 777, 736 . FTIR (NaCl, cm −1 ): 2976, 2926, 2868, 1701, 1647, 1496, 1469, 1423, 1363, 1252, 1170, 1142, 777, 735, 698 ORTEP drawings of 8ck (CCDC #1854746) showing atom numbering schemes and 50% probability ellipsoids. Boc-group at N1 is removed for clarity. Also, see Supporting Information for X-ray data of compounds 8da (CCDC #1854743), 8ga (CCDC #1854744), and 8ej (CCDC #1854745).
